Altus Wealth Group’s Dorman Products DORM Stock Holding History

Altus Wealth Group’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-50	Closed	-$4K	–	328
2020 Q4	$4K	Buy	+50	New	+$4.63K	﹤0.01%	678

Other funds holding DORM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Altus Wealth Group's DORM Position: Q1 2021 in Review

Altus Wealth Group sold out of Dorman Products (DORM) in Q1 2021, closing a stake of 50 shares — an estimated $4K sold.

Altus Wealth Group first reported a position in DORM in Q4 2020 and held it in 1 quarter. The position peaked at $4K in Q4 2020. 263 funds tracked by Wall St. Rank hold DORM as of Q1 2021.

Altus Wealth Group reported no remaining Dorman Products position as of Q1 2021 after selling out during the quarter.
Altus Wealth Group sold 50 Dorman Products shares in Q1 2021, an estimated $4K.
Altus Wealth Group first reported a position in Dorman Products in Q4 2020 and held it in 1 quarter.
Altus Wealth Group's Dorman Products position peaked at $4K in Q4 2020.
263 funds tracked by Wall St. Rank held Dorman Products as of Q1 2021.

Based on Altus Wealth Group's 13F filing for Q1 2021, filed 14 May 2021.